Certara expands PBPK simulator availability
Certara has developed a new licensing approach, which provides smaller organizations access to its physiologically-based pharmacokinetic (PBPK) modeling and simulation platform.
According to the company, Simcyp Access represents a new cloud-based licensing approach for pharmaceutical companies with less than 500 employees.
As Outsorucing-Pharma.com previously reported, Simcyp helps predict pharmacokinetic outcomes in virtual patient populations.
The most recent version of the simulator includes enhanced lung, pediatric, and GI transit models, as well as a new dermal absorption model, and a new report assistant.
In order to access the simulator on a rental basis, users must be previously trained on the platform.
Certara explained employees are considered trained if they have attended a Simcyp Workshop within the past three years.
